Patent Assignment
Reel/Frame 023834/0029
Change of Name
Recorded: 2010-01-22
Pages: 14
Assignor
MERCK & CO., INC.
Executed: 2009-11-02
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties
(59)
Human glycine transporter type 2
Application:
10/191,813 →
Publication:
US 2003/0165907
Octahydro-2-H-Naphtho[1,2-F]Indole-4-Carboxamide Derivatives as Selective Glucocorticoid Receptor Modulators
Application:
10/527,615 →
Publication:
US 2005/0245588
17-Carbamoyloxy Cortisol Derivatives as Selective Glucocorticoid Receptor Modulators
Method to Confer Cell Culture Replication Activity to Different Hepatitis C Virus Isolates
Method for treating mild cognitive impairment and for preventing or delaying alzheimer's disease
Application:
10/549,839 →
Publication:
US 2006/0241133
Biaryl substituted 6-membered heterocycles as sodium channel blockers
Application:
10/550,641 →
Publication:
US 2006/0293339
4-Ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
Application:
10/552,107 →
Publication:
US 2006/0217420
Splice variants of human voltage-gated calcium channel alpha2beta-2 subunit designated - alpha2beta-a and alpha2beta2-b
Application:
10/553,117 →
Forward Mutation Assay Based on 5-Fluorouracil Resistance
Combination therapy for the treatment of dyslipidemia
Application:
10/555,194 →
Publication:
US 2006/0148721
Use of selective cyclooxygenase-2 inhibitors for the treatment of endometriosis
Application:
10/559,676 →
Publication:
US 2006/0173062
Ccr-2 antagonists for treatment of neuropathic pain
Application:
10/559,701 →
Publication:
US 2006/0205761
Antibiotic Compounds
Opthalmic compositions for treating ocular hypertension
Application:
10/561,571 →
Publication:
US 2006/0148805
Combination therapy for treating chronic inflammatory diseases
Application:
10/561,672 →
Publication:
US 2007/0099926
Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator
Application:
10/564,029 →
Publication:
US 2006/0166972
Polypeptides for inducing a protective immune response against staphylococcus aureus
Application:
10/564,458 →
Publication:
US 2006/0177462
Hydroxypyridine Cgrp Receptor Antagonists
Application:
10/564,706 →
Publication:
US 2006/0173046
Mitotic Kinesin Inhibitors
Mitotic Kinesin Inhibitors
Bipyridyl Amines and Ethers as Modulators of Metabotropic Glutamate Receptor-5
Application:
10/570,068 →
Publication:
US 2007/0027321
Quinoline Potassium Channel Inhibitors
Substituted sulfonamides
Application:
10/571,842 →
Publication:
US 2007/0105914
Isoquinolinone Potassium Channel Inhibitors
Isoquinolinone Potassium Channel Inhibitors
Isoquinolinone Potassium Channel Inhibitors
Quinoline Potassium Channel Inhibitors
Isoquinoline Potassium Channel Inhibitors
Quinazoline Potassium Channel Inhibitors
Isoquinoline Potassium Channel Inhibitors
Isoquinolinone Potassium Channel Inhibitors
Benzylether and Benzylamino Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Transgenic Rodents Selectively Expressing Human B1 Bradykinin Receptor Protein
Application:
10/573,926 →
Publication:
US 2009/0007283
Prodrugs of Diaryl-2-(5H)-Furanone Cyclooxygenase-2 Inhibitors
Substituted Naphthyridinone Derivatives
Hcv Replicons Containing NS5B from Genetype 2B
Method of identifying responders to treatment with insulin sensitizers
Application:
10/578,811 →
Publication:
US 2007/0098636
Substituted Triazoles as Sodium Channel Blockers
Application:
10/578,950 →
Publication:
US 2009/0074890
Preservative-containing virus formulations
Application:
10/578,955 →
Publication:
US 2007/0148765
4-Phenyl piperdine sulfonyl glycine transporter inhibitors
Application:
10/579,261 →
Publication:
US 2007/0105902
Estrogen receptor modulators
Application:
10/579,651 →
Publication:
US 2007/0099880
Method for identifying androgen receptor modulators with full or mixed agonist activity
Application:
10/580,285 →
Publication:
US 2007/0141636
Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
Application:
10/581,166 →
Publication:
US 2007/0155660
Mitotic kinesin inhibitors
Application:
10/582,823 →
Publication:
US 2007/0060601
Alpha-Hydroxy Amides as Bradykinin Antagonists or Inverse Agonists
Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
Application:
10/585,232 →
Publication:
US 2007/0117797
Polynucleotides Encoding Coccidian Parasite Casein Kinase I, a Chemotherapeutic Target for Antiprotozoal Agents
6,11-3c-bicyclic 8a-azalide derivatives
Application:
10/586,415 →
Publication:
US 2009/0149398
Method of Treating Men with Metabolic and Anthropometric Disorders
Application:
10/594,373 →
Publication:
US 2008/0125403
Substituted Amides
Application:
11/109,076 →
Publication:
US 2005/0234061
Benzoxazinyl-Amidocyclopentyl-Heterocyclic Modulators of Chemokine Receptors
Cetp Inhibitors
Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
Potassium Salt of an Hiv Integrase Inhibitor
Inhibitor of vascular endothelial cell growth factor
Application:
11/375,523 →
Publication:
US 2007/0010442
Effervescent bisphosphonate formulation
Application:
11/390,114 →
Publication:
US 2007/0087052
System and Method for Automated Selection of T-Cell Epitopes
Dna Vaccine Formulations
Transgenic rodents as animal models for modulation of B1 bradykinin receptor protein
Application:
11/434,710 →
Publication:
US 2007/0011757
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name
Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Merger
Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →